Association Between Coronary Heart Disease and Inflammatory Biomarker YKL-40 in Type 2 Diabetes Subjects

被引：2
|
作者：
Kim, Hyun Min [1 ]
Jung, Chang Hee [2 ]
Cha, Bong Soo [1 ]
Lee, Hyun Chul [1 ]
Lee, Byung-Wan [1 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CARDIAC FAILURE | 2012年 / 18卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2012.06.055
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
051
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [31] Clinical significance of the elevated plasma YKL-40 levels in patients with coronary heart disease
    Zhang, Hui
    Tian, Chao-Wei
    Zhong, Yun
    Luo, Yi-Zhi
    Liu, Shi-Ming
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S7 - S7
  • [32] NEW INFLAMMATORY MARKER YKL-40 IS ASSOCIATED WITH EARLY RENAL FUNCTION DECLINE IN HYPERTENSIVE PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEASE AND TYPE 2 DIABETES MELLITUS
    Churakova, E.
    Shubina, A.
    Bolotina, M.
    Masenko, V.
    Karpov, Y.
    JOURNAL OF HYPERTENSION, 2017, 35 : E251 - E252
  • [33] Plasma YKL-40 A BMI-Independent Marker of Type 2 Diabetes
    Nielsen, Anders R.
    Erikstrup, Christian
    Johansen, Julia S.
    Fischer, Christian P.
    Plomgaard, Peter
    Krogh-Madsen, Rikke
    Taudorf, Sarah
    Lindegaard, Birgitte
    Pedersen, Bente K.
    DIABETES, 2008, 57 (11) : 3078 - 3082
  • [34] Plasma YKL-40 - A BMI-independent marker of type 2 diabetes
    Nielsen, Anders R.
    Johansen, Julia S.
    Fischer, Christian P.
    Plomgaard, Peter
    Krogh-Madsen, Rikke
    Pedersen, Bente K.
    DIABETES, 2008, 57 : A709 - A709
  • [35] High YKL-40 levels predict mortality in patients with type 2 diabetes
    Persson, Frederik
    Rathcke, Camilla Noelle
    Gall, Mari-Anne
    Parving, Hans-Henrik
    Vestergaard, Henrik
    Rossing, Peter
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 96 (01) : 84 - 89
  • [36] Plasma YKL-40 - a BMI-independent marker of type 2 diabetes
    Nielsen, A. R.
    Plomgaard, P.
    Johansen, J. S.
    Fischer, C. P.
    Krogh-Madsen, R.
    Pedersen, B. K.
    DIABETOLOGIA, 2008, 51 : S312 - S312
  • [37] Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease
    Schroder, Jakob
    Jakobsen, Janus Christian
    Winkel, Per
    Hilden, Jorgen
    Jensen, Gorm Boje
    Sajadieh, Ahmad
    Larsson, Anders
    Arnlov, Johan
    Harutyunyan, Marina
    Johansen, Julia S.
    Kjoller, Erik
    Gluud, Christian
    Kastrup, Jens
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
  • [38] Serum YKL-40 levels in patients with coronary artery disease
    Kucur, Mine
    Isman, Ferruh K.
    Karadag, Bilgehan
    Vural, Vural A.
    Tavsanoglu, Sedat
    CORONARY ARTERY DISEASE, 2007, 18 (05) : 391 - 396
  • [39] YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer's Disease
    Mavroudis, Ioannis
    Chowdhury, Rumana
    Petridis, Foivos
    Karantali, Eleni
    Chatzikonstantinou, Symela
    Balmus, Ioana Miruna
    Luca, Iuliana Simona
    Ciobica, Alin
    Kazis, Dimitrios
    MEDICINA-LITHUANIA, 2022, 58 (01):
  • [40] Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes
    Thomsen, Stine B.
    Gjesing, Anette P.
    Rathcke, Camilla N.
    Ekstrom, Claus T.
    Eiberg, Hans
    Hansen, Torben
    Pedersen, Oluf
    Vestergaard, Henrik
    PLOS ONE, 2015, 10 (07):
12345